LV15831A - 4-((5-substituted-4-oxo-4,5-dihydrothiazol-2-yl)amino)benzenesulfonamide derivatives as potential agents for neuropathic pain - Google Patents

4-((5-substituted-4-oxo-4,5-dihydrothiazol-2-yl)amino)benzenesulfonamide derivatives as potential agents for neuropathic pain

Info

Publication number
LV15831A
LV15831A LVLVP2022000080A LVP2022000080A LV15831A LV 15831 A LV15831 A LV 15831A LV LVP2022000080 A LVLVP2022000080 A LV LVP2022000080A LV P2022000080 A LVP2022000080 A LV P2022000080A LV 15831 A LV15831 A LV 15831A
Authority
LV
Latvia
Prior art keywords
dihydrothiazol
oxo
amino
substituted
neuropathic pain
Prior art date
Application number
LVLVP2022000080A
Other languages
Latvian (lv)
Inventor
Morteza ABDOLI
Raivis ŽALUBOVSKIS
Alessio NOCENTINI
Claudiu Trandafir SUPURAN
Original Assignee
Rīgas Tehniskā Universitāte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rīgas Tehniskā Universitāte filed Critical Rīgas Tehniskā Universitāte
Priority to LVLVP2022000080A priority Critical patent/LV15831A/en
Publication of LV15831A publication Critical patent/LV15831A/en

Links

LVLVP2022000080A 2022-09-30 2022-09-30 4-((5-substituted-4-oxo-4,5-dihydrothiazol-2-yl)amino)benzenesulfonamide derivatives as potential agents for neuropathic pain LV15831A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
LVLVP2022000080A LV15831A (en) 2022-09-30 2022-09-30 4-((5-substituted-4-oxo-4,5-dihydrothiazol-2-yl)amino)benzenesulfonamide derivatives as potential agents for neuropathic pain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LVLVP2022000080A LV15831A (en) 2022-09-30 2022-09-30 4-((5-substituted-4-oxo-4,5-dihydrothiazol-2-yl)amino)benzenesulfonamide derivatives as potential agents for neuropathic pain

Publications (1)

Publication Number Publication Date
LV15831A true LV15831A (en) 2024-04-20

Family

ID=90716747

Family Applications (1)

Application Number Title Priority Date Filing Date
LVLVP2022000080A LV15831A (en) 2022-09-30 2022-09-30 4-((5-substituted-4-oxo-4,5-dihydrothiazol-2-yl)amino)benzenesulfonamide derivatives as potential agents for neuropathic pain

Country Status (1)

Country Link
LV (1) LV15831A (en)

Similar Documents

Publication Publication Date Title
MX2022012616A (en) Atazanavir (atv) analogues for treating hiv infections.
MX2020006315A (en) Triazole n-linked carbamoyl cyclohexyl acids as lpa antagonists.
MX2020005323A (en) Cyclohexyl acid triazole azines as lpa antagonists.
MX2022011365A (en) Biaryl derivatives as yap/taz-tead protein-protein interaction inhibitors.
NO20033732L (en) N-substituted non-aryl heterocyclic NMDA / NR2B antagonists, and pharmaceutical compositions comprising such compounds.
WO2018187553A8 (en) Fungicidal oxadiazoles
MX2020005818A (en) Cyclohexyl acid triazole azoles as lpa antagonists.
NO20090628L (en) Pyridizinone derivatives
FI3723783T3 (en) Mitochondria-targeting peptides
NO20092412L (en) Hydantoin derivatives are used as MMP inhibitors
DK3724191T3 (en) 5- (2- (2,5-DIFLUOROPHENYL) PYRROLIDIN-1-YL) -3- (1H-PYRAZOL-1-YL) PYRAZOLE [1,5-A] PYRIMIDINE DERIVATIVES AND SIMILAR COMPOUNDS LIKE TRK-CHINASE INHIBITORS C
EA202192029A1 (en) SUBSTITUTED DERIVATIVES OF 3- (1-OXOISOINDOLIN-2-YL) PIPERIDINE-2,6-DIONE AND VARIANTS OF THEIR APPLICATION
NO20084923L (en) N- (2-thiazolyl) -amide derivatives as GSK-3 inhibitors
NO20073859L (en) Pyrrolopyrazoles, potent kinase inhibitors
NO20061701L (en) Thiazole derivatives as cannabionoid receptor modulators
IL194744A (en) 1-(alkyl)-3-(substituted amino)-5-(substituted) s-triazole derivatives, process for their preparation and pharmaceutical compositions comprising same for treating psychotic disorders
MX2007007025A (en) Novel hydantoin derivatives as metalloproteinase inhibitors.
SA520411787B1 (en) Benzimidazole derivatives and their uses
EP4217352A4 (en) Substituted n-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)arylsulfonamide analogs as modulators of cereblon protein
MX2021014680A (en) Benzotriazole derivative.
MX2023000926A (en) Novel pyrazole derivatives.
LV15831A (en) 4-((5-substituted-4-oxo-4,5-dihydrothiazol-2-yl)amino)benzenesulfonamide derivatives as potential agents for neuropathic pain
MX2021003545A (en) Crystalline forms of n-(1 -((2-(dimethylamino)ethyl)amino)-2-m ethyl-1 -oopropan-2-yl)-4-(4-(2-methyl-5- (2s,3r,4r,5s,6r)-3,4,5 -trihydroxy-6-(methylthio)tetrahydro-2h-pyran-2-yl)benzyl) phenl)butanamide and methods of their synthesis.
WO2007025776A3 (en) Cysteine protease inhibitors
EP4079293A4 (en) Liquid pharmaceutical composition of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrole-3-yl)-n-methylmethaneamine